bioMérieux has today acquired the entire capital and voting rights of Skiva (441 886 728 R.C.S. Paris), the parent company of the AES Chemunex group.
Asia
Europe, Middle East, Africa
North America
bioMérieux Expands its Infectious Disease Offering with Acquisition of ARGENE, Specialized in Molecular Diagnostics for Immunocompromised Patients
19 July, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has acquired ARGENE, a French company specialized in molecular diagnostics. This acquisition is bioMérieux’s tenth in the last five years.
bioMérieux - First-Half 2011 Business Review
19 July, 2011
bioMerieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2011.
bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety
22 June, 2011
VIDAS® UP Recombinant Phage Technology Delivers Unprecedented Specificity and Sensitivity for Rapid and Reliable Testing
IAFP Names bioMérieux, Inc. as Recipient of the Prestigious Black Pearl Award
31 May, 2011
The International Association for Food Protection (IAFP) selected bioMerieux, Inc., as the 2011 recipient of the prestigious Black Pearl Award. Sponsored by Wilbur Feagan and F & H Food Equipment Company, the Black Pearl Award will be presented at IAFP's Annual Meeting in Milwaukee, Wisconsin in August.
bioMérieux Gains International Approval for its Automated Solution: VIDAS® Easy Salmonella
26 May, 2011
AOAC Official Methods(SM) Approval Underscores VIDAS® Excellence in Food Safety Testing
U.S. FDA Recommends bioMérieux's VIDAS® Staphylococcal Enterotoxin Assay (SET2) as Primary Screening Method for Food Safety Testing
26 May, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, announced today that the VIDAS® Staphylococcal enterotoxins assay (SET2) has been included in the United States Food and Drug Administration’s (FDA) Bacteriological Analytical Manual (BAM) for food safety testing. The FDA’s BAM is recommending that the VIDAS SET2 protocol be used as the primary screening method for the presence of Staphylococcal enterotoxins in suspect food samples and culture isolates.
bioMérieux Receives FDA Clearance for NucliSENS® EasyQ MRSA, Automated, Rapid Molecular Screening Unit
24 May, 2011
Company Offers Most Comprehensive, Cost-Effective Suite of Solutions to Detect and Screen for Methicillin Resistant Staphylococcus aureus (MRSA)
bioMérieux Presents 2011 Sonnenwirth Award for Leadership in Clinical Microbiology to Melvin Weinstein
23 May, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, is proud to announce Melvin Weinstein, M.D., as the 2011 recipient of the bioMérieux Sonnenwirth Award for Leadership in Clinical Microbiology.
bioMérieux Becomes the World Leader in Food Testing with AES Laboratoire Acquisition
20 May, 2011
bioMérieux, a world leader in the field of in vitro diagnostics, has signed an agreement to acquire AES Laboratoire, a leading French group, specialized in industrial microbiological control, for 183 million euros. This will be bioMérieux’s ninth acquisition in five years and its third in the area of industrial applications.